TB

This fact sheet provides information regarding TB/HIV coinfection worldwide. It also presents key activities being conducted by the WHO in response to TB/HIV coinfection.

This document describes nineteen (19) new or improved diagnostic tools of the many that have been or are being developed. WHO has a process for evaluating and endorsing new tools for TB control programmes. Three (3) of the tools described in this document have already been endorsed by WHO and are being implemented by countries, while the others are still under development or in piloting phase and are expected to be ready for review for appropriateness for scaled-up use in the coming years.

This pamphlet explains how to collect a sputum specimen at home for laboratory analysis.

This pamphlet explains how to collect a sputum specimen at home for laboratory analysis.

This pamphlet is for friends and family members of individuals with TB. It discusses transmission, symptoms of active TB, TB testing, and what individuals should do if they test positive.

This facilitator-led guide is intended to build internal capacity within TB programs by assisting trainers to educate their colleagues on issues of cultural proficiency.

This toolkit is an interactive resource designed for TB control and advocacy efforts. It allows users to search for and choose information, such as publications, chapters, and tools, in order to create their own advocacy materials.

The questionnaire is a survey instrument that can be used to determine which health-care staff are involved in managing TB patients at the primary care level in National TB Programs that follow the DOTS strategy, and to assess the time needed to perform the tasks related to TB care. It is intended as a survey instrument, not as a planning tool.

The poster from the Toronto Public Health raises awareness about signs and symptoms of TB and initiating infection control to protect and prevent the spread of TB among patients and hospital staff.

Treatment Action Group (TAG) analyzes and reports on the annual
funding of tuberculosis (TB ) research and development (R&D). The top 40 TB
research funding institutions were surveyed for actual disbursements made for TB
R&D in fiscal years 2005, 2006, and now 2007. The three-year data reveal trends in
funding and demonstrates an alarming shortfall in the growth of TB R&D during the
initial years covered by The Global Plan to Stop TB: 2006–2015.